Intelligent Investment
Sydney Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read
Overview
- Sydney is home to the largest share of life sciences firms in Australia, many of which are among the world’s leading biopharmaceutical companies.
- The Sydney Biomedical Accelerator (due for completion by 2027) should accelerate research in the fields of cancer, cardiovascular disease, infectious diseases and immunity, and neuroscience and mental health.
- Sydney’s life sciences sector underpins a broader ecosystem across the state of New South Wales, employing thousands of individuals and extending to regional areas such as Newcastle and Wollongong.
- Two of the world’s leading universities are located in New South Wales, providing a pipeline of top talent to the industry, including the University of Sydney and the University of New South Wales (UNSW).
Submarkets
- Camperdown: Location of the Sydney Biomedical Acceleratory and the Royal Prince Alfred Hospital and University of Sydney’s Camperdown campus
- Westmead: One of the largest health precincts in Australia that includes Westmead Hospital, the Children’s Hospital at Westmead and several research institutes
- Randwick: A major health and research precinct that hosts the Prince of Wales Hospital, UNSW and several research centers
- Macquarie Park: A growing hub for biotech and pharmaceutical companies and site of a new RNA research and pilot manufacturing facility for research, development and production of a broad spectrum of RNA technologies
- Liverpool: Known for its health and academic institutions
- Royal North Shore: Hosts the Royal North Shore Hospital and associated research facilities
Industry Presence
- Thirty-seven percent of Australian life sciences companies and 34% of the country’s life sciences employment are located in New South Wales
Life Sciences Venture Capital Investment Trends
Figure 1: Life Sciences Venture Capital Funding
- AstraZeneca
- Cochlear
- Johnson & Johnson
- Novartis
- SpeeDx
- Vitex Pharmaceuticals
- Garvan Institute
- Prince of Wales Hospital
- Royal North Shore Hospital
- Royal Prince Alfred Hospital
- St Vincent’s Hospital
- The Children’s Hospital at Westmead
- The George Institute
- University of New South Wales (UNSW)
- University of Sydney
- Westmead Hospital
- Westmead Institute for Medical Research (WIMR)
Global Life Science Markets
-
Melbourne is the leading hub for life sciences in Australia, providing a comprehensive ecosystem of cutting-edge biotechnology, pharmaceuticals, medical research, healthcare innovation and manufacturing.
-
Shanghai stands as one of China’s two comprehensive life sciences clusters, alongside Beijing, offering a spectrum of research and development (R&D).
-
Singapore is one of the few markets in Asia-Pacific with a full end-to-end value chain—manufacturing, research and development (R&D), sales and logistics.